PCSK9 Inhibitor Market Set to Surge to USD 15,140.3 Million by 2034, Driven by Soaring Cardiovascular Disease Rates and Demand for Advanced Cholesterol Therapies | FMI

The global PCSK9 inhibitor market is on a trajectory of substantial expansion, with its valuation expected to reach USD 2,733.7 million by the end of 2024, marking a year-on-year growth rate of 21.5%. Over the next decade, the market is projected to grow at a robust CAGR of 18.7%, eventually reaching USD 15,140.3 million by …

PCSK9 Inhibitor Market to Surge with 21.5% Growth, Projected to Reach USD 15,140.3 Million by 2034

The global PCSK9 inhibitor market is set to experience substantial growth, with an estimated market size of USD 2,733.7 million in 2024, reflecting a year-over-year growth of 21.5%. The market is projected to expand at a robust compound annual growth rate (CAGR) of 18.7% throughout the forecast period, with total sales anticipated to reach approximately …